RTW Charitable Foundation is proud to announce an open call for its Research Grant Cycle to support work aimed at developing therapeutics for ultrarare diseases.
Donor Name: RTW Charitable Foundation
Country: Global
Type of Grant: Grant
Deadline: 05/31/2023
Size of the Grant: up to $150,000
Grant Duration: 1 year
Details:
The mission of the RTW Charitable Foundation is to power rare-disease research, medical innovation, and humanitarian collaborations to improve the health of underserved communities.
Funding Information
The 2023 Grants will provide up to $150,000 for one year to support translational projects that bridge the gap between proof-of-concept studies in animal models and preclinical safety/toxicology studies.
Eligibility Criteria
The Request for Proposals is open to:
- Any scientists or clinicians affiliated with a higher-education research institution or healthcare organization anywhere in the world (projects led by patient organizations are also welcome)
- Diseases that affect fewer than 2000 patients worldwide (monogenetic, life-threatening conditions affecting fewer than 300 patients worldwide preferred)
- Diseases for which no commercial drug-development programs exist
- Projects in any therapeutic area
- Projects that involve any clinically validated therapeutic modality (gene-replacement and antisense oligonucleotide-based therapies preferred)
- Projects for which there is evidence that the proposed therapeutic modality works in an animal model (or in another suitable system)
For more information, visit RTW Charitable Foundation.
